UBS Maintains Neutral on UnitedHealth Group, Raises Price Target to $520
Portfolio Pulse from richadhand@benzinga.com
UBS analyst Kevin Caliendo maintains a Neutral rating on UnitedHealth Group (NYSE:UNH) and raises the price target from $510 to $520.
July 19, 2023 | 3:34 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS maintains a Neutral rating on UnitedHealth Group and raises the price target from $510 to $520. This could potentially influence investor sentiment.
The news is directly about UnitedHealth Group. The raised price target indicates a positive outlook, but the Neutral rating suggests that the stock is fairly valued at the moment. This could influence investor sentiment but is unlikely to cause significant price movement in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100